Psychemedics Corporation (PMD)

NASDAQ: PMD · IEX Real-Time Price · USD

2.350

-0.020 (-0.84%)

At close: Jul 2, 2024, 4:00 PM

2.430

+0.080 (3.40%)

After-hours: Jul 2, 2024, 6:16 PM EDT

Psychemedics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 1994
Net Income	-4.15	-1.08	-0.67	-3.86	1.54	Upgrade
Depreciation & Amortization	2.67	3.32	3.69	3.63	2.91	Upgrade
Share-Based Compensation	0.91	0.87	0.74	0.56	0.76	Upgrade
Other Operating Activities	-0.9	1.79	-3.35	-4.41	-0.91	Upgrade
Operating Cash Flow	-1.48	4.89	0.41	-4.08	4.31	Upgrade
Operating Cash Flow Growth	-	1081.16%	-	-	-45.66%	Upgrade
Capital Expenditures	-0.16	-0.19	-0.18	-0.85	-1.68	Upgrade
Change in Investments	0	0	0	0	3.81	Upgrade
Other Investing Activities	-0	-0.02	-0.04	-0.01	-0.06	Upgrade
Investing Cash Flow	-0.16	-0.21	-0.22	-0.86	2.08	Upgrade
Dividends Paid	-0.8	-1.19	-0.28	-0.99	-3.97	Upgrade
Share Issuance / Repurchase	-0.05	-0.07	-0.07	-0.01	-0.03	Upgrade
Debt Issued / Paid	-0.29	-0.66	-0.69	1.5	1	Upgrade
Financing Cash Flow	-1.15	-1.92	-1.04	0.5	-3	Upgrade
Exchange Rate Effect	0	0	0	-0.01	-0.17	Upgrade
Net Cash Flow	-2.79	2.76	-0.84	-4.45	3.21	Upgrade
Free Cash Flow	-1.64	4.7	0.23	-4.93	2.63	Upgrade
Free Cash Flow Growth	-	1927.16%	-	-	-60.94%	Upgrade
Free Cash Flow Margin	-7.41%	18.63%	0.93%	-23.10%	6.99%	Upgrade
Free Cash Flow Per Share	-0.28	0.84	0.04	-0.89	0.48	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).